Robert Clare

Duke Clinical Research Institute
Chapel Hill, NC
USA

Papers:

Significant reduction in mortality following single administration of autologous CD34 cells in the orphan indication of No-Option Refractory Disabling Angina (NORDA): Re-analysis of the largest completed study of CD34 cell therapy